Harrow Inc
Research Harrow Inc (HROW) on Bullrun: market cap USD 1.55B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHROW
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 1.55B
- Financial periodQ1 2026
- RevenueUSD 44.20M
- Net income-USD 14.96M
- Free cash flow-USD 27.20M
- Gross margin450.4%
Valuation Snapshot
latest market cap is USD 1.55B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 272.30M | -USD 5.14M | USD 42.98M | 75.1% | -0.14 | USD 72.93M | USD 250.00M | USD 52.45M |
| FY2024 | USD 199.61M | -USD 17.48M | -USD 23.80M | 75.3% | -0.49 | USD 47.25M | USD 262.74M | USD 69.65M |
| FY2023 | USD 130.19M | -USD 24.41M | USD 2.38M | 69.6% | -0.75 | USD 74.09M | USD 246.72M | USD 70.77M |
| FY2022 | USD 88.60M | -USD 14.09M | -USD 892.00K | 71.3% | -0.51 | USD 96.27M | USD 151.77M | USD 27.60M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.55B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.82B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.20B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 393.32M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 439.70M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 232.44M | n/a | n/a | n/a |
About Harrow Inc
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE, as well as BYQLOVI; MAXITROL eye drops;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Harrow Inc's market cap?
Harrow Inc's market capitalization is USD 1.55B.
What does Harrow Inc do?
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications.